Drawing for RAZOKO

USPTO serial 88477243

RAZOKO

Reviewed by CopyMark Law Group

Reg. 5965573Status 701Registered
Filing date
Status date
Registration date
Jan 21, 2020
Examiner
SETTLES LEWIS, SHAILA E
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with RAZOKO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
021Dental floss; dental floss picksACTIVEFeb 4, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 27, 2026NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jul 27, 20268.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jul 27, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 23, 2026ES8RTEAS SECTION 8 RECEIVED
May 22, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 22, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 22, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 22, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 21, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 6, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 30, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 30, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 30, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 30, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 30, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 21, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 5, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 24, 2019PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2019DOCKASSIGNED TO EXAMINER
Jun 28, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 21, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance